Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FDK07
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,565
Award facts
- Contract value 100% obligated
- $25,564.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price contract valued at $25,564.66 for the supply of Alecensa 150 mg capsules (240-count units). The award, issued on June 13, 2025, with an ultimate completion date of July 8, 2025, is funded by the Defense Logistics Agency (DLA), the Department of Defense's logistics component responsible for managing medical supply chains across military healthcare facilities. No set-aside designation was applied to this award.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. That master contract enables the agency to procure a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare requirements. Alecensa, a prescription oncology medication, represents the type of specialized pharmaceutical product the company routinely supplies to military medical facilities nationwide under this framework agreement.
Quick answers
Who was awarded contract SPE2DB25FDK07?
SPE2DB25FDK07 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 13, 2025.
How much is contract SPE2DB25FDK07 worth?
The government has obligated $25,565 on SPE2DB25FDK07.
Is contract SPE2DB25FDK07 an order under another contract?
Yes. SPE2DB25FDK07 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDK07 competed?
The extent of competition for SPE2DB25FDK07 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award